chr15-40208785-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001211.6(BUB1B):​c.2143+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.526 in 1,599,102 control chromosomes in the GnomAD database, including 226,339 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 17323 hom., cov: 31)
Exomes 𝑓: 0.53 ( 209016 hom. )

Consequence

BUB1B
NM_001211.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.522

Publications

6 publications found
Variant links:
Genes affected
BUB1B (HGNC:1149): (BUB1 mitotic checkpoint serine/threonine kinase B) This gene encodes a kinase involved in spindle checkpoint function. The protein has been localized to the kinetochore and plays a role in the inhibition of the anaphase-promoting complex/cyclosome (APC/C), delaying the onset of anaphase and ensuring proper chromosome segregation. Impaired spindle checkpoint function has been found in many forms of cancer. [provided by RefSeq, Jul 2008]
BUB1B Gene-Disease associations (from GenCC):
  • mosaic variegated aneuploidy syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • mosaic variegated aneuploidy syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 15-40208785-C-T is Benign according to our data. Variant chr15-40208785-C-T is described in ClinVar as Benign. ClinVar VariationId is 257634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.554 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BUB1BNM_001211.6 linkc.2143+15C>T intron_variant Intron 16 of 22 ENST00000287598.11 NP_001202.5
LOC107984763XR_001751506.2 linkn.218-28584G>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BUB1BENST00000287598.11 linkc.2143+15C>T intron_variant Intron 16 of 22 1 NM_001211.6 ENSP00000287598.7
BUB1BENST00000412359.7 linkc.2185+15C>T intron_variant Intron 16 of 22 2 ENSP00000398470.3

Frequencies

GnomAD3 genomes
AF:
0.463
AC:
70222
AN:
151798
Hom.:
17310
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.301
Gnomad AMI
AF:
0.636
Gnomad AMR
AF:
0.479
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.259
Gnomad SAS
AF:
0.478
Gnomad FIN
AF:
0.557
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.559
Gnomad OTH
AF:
0.441
GnomAD2 exomes
AF:
0.493
AC:
123325
AN:
250390
AF XY:
0.497
show subpopulations
Gnomad AFR exome
AF:
0.298
Gnomad AMR exome
AF:
0.506
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.558
Gnomad NFE exome
AF:
0.556
Gnomad OTH exome
AF:
0.489
GnomAD4 exome
AF:
0.533
AC:
770770
AN:
1447184
Hom.:
209016
Cov.:
33
AF XY:
0.533
AC XY:
383961
AN XY:
720986
show subpopulations
African (AFR)
AF:
0.294
AC:
9775
AN:
33246
American (AMR)
AF:
0.507
AC:
22658
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.395
AC:
10292
AN:
26068
East Asian (EAS)
AF:
0.282
AC:
11160
AN:
39630
South Asian (SAS)
AF:
0.481
AC:
41327
AN:
85946
European-Finnish (FIN)
AF:
0.558
AC:
29363
AN:
52648
Middle Eastern (MID)
AF:
0.406
AC:
2329
AN:
5734
European-Non Finnish (NFE)
AF:
0.559
AC:
614321
AN:
1099280
Other (OTH)
AF:
0.493
AC:
29545
AN:
59938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
16457
32915
49372
65830
82287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16888
33776
50664
67552
84440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.463
AC:
70267
AN:
151918
Hom.:
17323
Cov.:
31
AF XY:
0.461
AC XY:
34243
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.301
AC:
12456
AN:
41446
American (AMR)
AF:
0.480
AC:
7334
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1392
AN:
3470
East Asian (EAS)
AF:
0.259
AC:
1332
AN:
5150
South Asian (SAS)
AF:
0.479
AC:
2302
AN:
4808
European-Finnish (FIN)
AF:
0.557
AC:
5859
AN:
10516
Middle Eastern (MID)
AF:
0.431
AC:
125
AN:
290
European-Non Finnish (NFE)
AF:
0.559
AC:
37950
AN:
67944
Other (OTH)
AF:
0.444
AC:
938
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1813
3627
5440
7254
9067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.386
Hom.:
3339
Bravo
AF:
0.447
Asia WGS
AF:
0.356
AC:
1238
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mosaic variegated aneuploidy syndrome 1 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Colorectal cancer Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Premature chromatid separation trait Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.5
DANN
Benign
0.30
PhyloP100
-0.52
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11630664; hg19: chr15-40500986; COSMIC: COSV55016029; COSMIC: COSV55016029; API